Literature DB >> 15307000

Acute pain in herpes zoster and its impact on health-related quality of life.

Jennifer Katz1, Edith M Cooper, Robert R Walther, Eugene W Sweeney, Robert H Dworkin.   

Abstract

Although the effects of postherpetic neuralgia on physical and emotional functioning have been examined in a number of studies, the impact of acute pain in herpes zoster ("shingles") on health-related quality of life has been neglected. We describe the characteristics of herpes zoster pain and examine its relationship to physical, role, social, and emotional functioning in 110 patients with herpes zoster. When we controlled for relevant covariates, we found that greater pain burden, as assessed by the product of pain intensity and duration, was associated with poorer physical functioning, increased emotional distress, and decreased role and social functioning. The results demonstrate that herpes zoster pain has broad effects on the daily lives of patients and on their emotional health. The increasing incidence of herpes zoster that can be anticipated as the population ages requires that clinical trials that examine interventions to prevent or treat herpes zoster pain be given a high priority.

Entities:  

Mesh:

Year:  2004        PMID: 15307000     DOI: 10.1086/421942

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  72 in total

1.  The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study.

Authors:  Mélanie Drolet; Marc Brisson; Kenneth E Schmader; Myron J Levin; Robert Johnson; Michael N Oxman; David Patrick; Caty Blanchette; James A Mansi
Journal:  CMAJ       Date:  2010-10-04       Impact factor: 8.262

2.  Risk factors for chronic pain following breast cancer surgery: a prospective study.

Authors:  Ellen L Poleshuck; Jennifer Katz; Carl H Andrus; Laura A Hogan; Beth F Jung; Dale I Kulick; Robert H Dworkin
Journal:  J Pain       Date:  2006-09       Impact factor: 5.820

3.  Presentation and management of herpes zoster (shingles) in the geriatric population.

Authors:  Kenneth R Cohen; Rebecca L Salbu; Jerry Frank; Igor Israel
Journal:  P T       Date:  2013-04

4.  Herpes zoster on the face in the elderly.

Authors:  Preeti Nair; Harshkant Gharote; Pooja Singh; Palak Jain-Choudhary
Journal:  BMJ Case Rep       Date:  2014-10-19

Review 5.  Cost-effectiveness of vaccination against herpes zoster.

Authors:  Pieter T de Boer; Jan C Wilschut; Maarten J Postma
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

6.  The burden of disease of Herpes Zoster in Tuscany.

Authors:  Miriam Levi; Irene Bellini; Leonardo Capecchi; Luca Pieri; Angela Bechini; Sara Boccalini; Silvia Callaioli; Roberto Gasparini; Donatella Panatto; Emilia Tiscione; Paolo Bonanni
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

Review 7.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

8.  Impact of herpes zoster and post-herpetic neuralgia on patients' quality of life: a patient-reported outcomes survey.

Authors:  Thomas Weinke; Alexander Edte; Sonja Schmitt; Kati Lukas
Journal:  Z Gesundh Wiss       Date:  2010-03-21

9.  Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study.

Authors:  Leonardo Emberti Gialloreti; Monica Merito; Patrizio Pezzotti; Luigi Naldi; Antonio Gatti; Maud Beillat; Laurence Serradell; Rafaelle di Marzo; Antonio Volpi
Journal:  BMC Infect Dis       Date:  2010-08-03       Impact factor: 3.090

10.  Acupuncture in acute herpes zoster pain therapy (ACUZoster) - design and protocol of a randomised controlled trial.

Authors:  Johannes Fleckenstein; Sybille Kramer; Philipp Hoffrogge; Sarah Thoma; Philip M Lang; Lukas Lehmeyer; Gabriel M Schober; Florian Pfab; Johannes Ring; Peter Weisenseel; Klaus J Schotten; Ulrich Mansmann; Dominik Irnich
Journal:  BMC Complement Altern Med       Date:  2009-08-12       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.